Literature DB >> 2286593

Concentrations of ofloxacin in human bone and in cartilage.

A Meissner1, K Borner, P Koeppe.   

Abstract

Concentrations of ofloxacin were determined in bone, cartilage and serum of 23 patients (8 male, 15 female; age 29-85 years) who underwent total hip replacement for osteoarthritis. A single dose of 200 mg ofloxacin was infused over a period of 20 min. Blood specimens (total 89), bone (45), and cartilage specimens were taken up to 720 min after the infusion. Ofloxacin was determined by high performance liquid chromatography. Bone was extracted with buffer three times to obtain a complete extraction. An average bone density of 1.9 kg/l was assumed in order to convert concentrations from mg/kg to mg/l bone. Mean serum concentrations decreased from 7.2 +/- 2.6 (0 min) to 0.5 +/- 0.1 (720 min). Mean tissue concentrations (mg/l) at 98, 246 and 716 min after the end of infusion were, in cortical bone 0.64 +/- 0.29, 0.86 +/- 0.55 and 0.59 +/- 0.14; in cancellous bone, 1.70 +/- 0.72, 1.47 +/- 1.00 and 0.99 +/- 0.43, and in cartilage 1.38 +/- 1.05; 2.19 +/- 1.56 and 2.18 +/- 0.45. The half-life of ofloxacin in tissues was longer than in serum. No side effects were observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2286593     DOI: 10.1093/jac/26.suppl_d.69

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet.

Authors:  M Shakibaei; K Pfister; R Schwabe; J Vormann; R Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Quinolones in children. Are concerns over arthropathy justified?

Authors:  R Stahlmann; C Förster; D Van Sickle
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

Review 4.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 5.  Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.

Authors:  D P Lew; F A Waldvogel
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats.

Authors:  Edith Lozo; Kai Riecke; Rudolf Schwabe; Jürgen Vormann; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.

Authors:  R Stahlmann; U Zippel; C Förster; R Schwabe; M Shakibaei; H J Merker; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 8.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 9.  Quinolones and osteomyelitis: state-of-the-art.

Authors:  D P Lew; F A Waldvogel
Journal:  Drugs       Date:  1995       Impact factor: 9.546

10.  Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation.

Authors:  Cornelia B Landersdorfer; Martina Kinzig; Jürgen B Bulitta; Friedrich F Hennig; Ulrike Holzgrabe; Fritz Sörgel; Johannes Gusinde
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.